Janssen (Johnson & Johnson) COVID-19 Vaccine Fact Sheet

On February 27, 2021, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older.

Publication Date: 04/08/2021
Document Type: Informational Pages
Sponsor: Department of Health

Summary
Fact sheets available in the following languages.
English, Arabic, Russian, Chinese (Simplified), Spanish, Vietnamese

For additional languages, please visit www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19-vaccine

Need Help Viewing?

You need a program that can open Adobe PDF files. A free option:

Was this page helpful?      



Comments are helpful!
500 character limit

Feedback is anonymous.